Chemical Segment Targets ¥40 Billion in FY2025 Sales and a 50% New Product Ratio
First written in FY2017. 1 of 4 entries say "Restated". Latest entry: FY2023.
Sumitomo Seika Chemicals Company,Limited. moved to the "Worse" side of this theme in 2020.
The whole theme swung hardest in 2021: 2 of 7 companies on the "Worse" side.
1 other company's latest entry also says "Reframed".
- FY2023ReframedAnnual report
「Fiscal 2025 plan: Functional Materials 400; revenue 1,600」
The target has been changed from the previous Chemicals segment target of fiscal 2025 revenue of ¥40 billion and a 50% new product ratio to fiscal 2025 revenue of ¥40 billion for the Functional Materials business, which integrates Functional Chemicals and Gas, changing the target's unit and presentation. - FY2020SoftenedAnnual report
「Under this plan, the Company is targeting fiscal 2022 revenue of ¥24 billion and operating profit of ¥2.8 billion.」
The previous Chemicals segment targets of fiscal 2025 revenue of ¥40 billion and a 50% new product ratio have been replaced by fiscal 2022 targets for the Functional Chemicals segment of revenue of ¥24 billion and operating profit of ¥2.8 billion. - FY2018RestatedAnnual report
「The Company aims to achieve a business structure in fiscal 2025 with revenue of ¥40 billion, half of which will come from new products.」
There is no change to the Chemicals segment's fiscal 2025 targets of revenue of ¥40 billion and a 50% new product ratio. - FY2017First statedAnnual report
「In the Chemicals segment, the Company will pursue R&D centered on its strengths in functionality, namely “thickening” and “adhesion,” and in technology, namely “synthesis and purification” and “processing.” By creating new businesses and products in Japan and overseas, particularly in the Healthcare & Life and Environment & Energy fields among its main domains, it aims to give concrete form to “vitality (URUOI)” and achieve a business structure in fiscal 2025 with revenue of ¥40 billion, half of which will come from new products.」
Through R&D and the creation of new businesses and products, the Company is targeting a business structure in fiscal 2025 with revenue of ¥40 billion, half of which will come from new products.